Clinical research strongly supports IG-SRT’s effectiveness. For example, a large 2021 study analyzed 2,917 skin cancer lesions (basal and squamous cell) treated with image-guided SRT and found a 99.3% cure rate. This is a remarkable outcome, essentially indicating that virtually all treated tumors were eliminated. Further studies published in 2022 and 2023 confirmed that IG-SRT not only maintains high cure rates but also results in better safety and cosmetic outcomes compared to older forms of radiotherapy. In surveys of thousands of patients who have completed IG-SRT, over 99% report being happy with their results and would recommend the treatment to others. These research findings have led experts to consider IG-SRT a first-line therapy alongside surgery. In summary, the scientific evidence shows that IG-SRT is an extremely effective and safe way to cure non-melanoma skin cancers, with outcomes on par with the best surgical methods.
Category:
IG-SRT



